Entheon Biomedical

Entheon Biomedical is a listed (CSE:ENBI) company that aims to develop DMT for addiction treatment.

Entheon Biomedical

The company went public on the Canadian Securities Exchange (CSE) on the 12th of November.

From their website: “Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule. Entheon exists to invert the addiction-recovery ratio, turning the ‘untreatable case’ and ‘lost cause’ from the norm to the exception.

The company is funded (in part) by Synaptic Ventures.

Key Staff

Company Information

Entheon Biomedical Website

January, 2020


B2B B2C Biotech

Topics of Interest

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office 595 Howe St, Vancouver, BC V6C 2T5, Canada